Clinical trial
Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent…
NCT00045721 · Pediatric Brain Tumor Consortium, Other · Terminated
Key facts
| NCT number | NCT00045721 |
|---|---|
| Title | Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma |
| Official title | Phase I Trial of GLIADEL and O(6)-Benzylguanine in Pediatric Patients With Recurrent Malignant Gliomas |
| Lead sponsor | Pediatric Brain Tumor Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure |
| Interventions | O6-benzylguanine, polifeprosan 20 with carmustine implant, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Enrollment | 3 |
| Start date | Mar 1, 2003 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 16, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: